LH
Laura Horvath
Hematology & Oncology
Credentials: · · ·
History
Research
The Lancet Oncology · 2018 · 625 citations
Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma
Annals of Oncology · 2016 · 100 citations
Journal of Oncology Practice · 2010 · First of 10 authors · 70 citations

3 papers
- BT
2 papers
- SD
2 papers
- WT
2 papers

1 paper
- AJ
1 paper
- BJ
1 paper
- CB
1 paper
Clinical trials
- 2009–2011
Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer
Principal investigator · Withdrawn · Phase 1
Loyola University

